Wird geladen...

Prostate Cancer Immunotherapy: The Path Forward

PURPOSE OF THIS REVIEW: To provide an overview of current strategies being investigated in the development of immunotherapy in prostate cancer. RECENT FINDINGS: Development of immunotherapy in prostate cancer actually began in 2010 with FDA approval of sipuleucel-T. Given that immune checkpoint inhi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curr Opin Support Palliat Care
Hauptverfasser: Madan, Ravi A., Gulley, James L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258656/
https://ncbi.nlm.nih.gov/pubmed/28644303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SPC.0000000000000278
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!